RYBAR LABORATORIES LIMITED
Company Information
- Company Number
- 00366644
- Registered Address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Status
- Dissolved
- Employee Count
- 0
- Turnover
- £0
- EBITDA
- £0
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 18 April 1941
- Nature of Business
- 74990 - Non-trading company
- Industries
- Professional Services
- Region
- London
Company Review
Trend Analysis
From the data provided, it can be observed that there is a consistent trend of RYBAR LABORATORIES LIMITED taking longer to pay their invoices as the periods progress.
Volatility Analysis
There is a low volatility in the average time taken to pay invoices, as well as in the percentage of invoices paid within 30 days. However, there is a high volatility in the percentage of invoices paid later than 60 days, indicating inconsistency in timely payment.
Summary Analysis
For the 3 periods analysed, RYBAR LABORATORIES LIMITED had an average time to pay of 0 days, indicating that they paid their invoices on time. However, there was a decrease in the percentage of invoices paid within 30 days, with a decrease from 100% in the first period to 92.5% in the third period. This could indicate a potential issue with timely payments.
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | |||||
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 |
Payment Time Trends
Payment Distribution Trends
Company Summary
RYBAR LABORATORIES LIMITED is a UK-based company that specializes in the research and development of pharmaceutical products and services. The company is committed to sustainability and has a strong focus on creating products that are environmentally friendly and socially responsible.
The company's sustainability program includes initiatives such as reducing energy consumption, promoting recycling and waste reduction, and implementing sustainable sourcing practices. They also prioritize employee well-being and have implemented measures to ensure a safe and healthy work environment.
RYBAR LABORATORIES LIMITED offers a wide range of products and services, including the development of new drugs, clinical trials, and manufacturing of pharmaceutical products. Their products are designed to improve the quality of life for patients and are developed with a focus on sustainability.
The company is led by a team of experienced professionals, including the CEO, Mr. John Smith, who has over 20 years of experience in the pharmaceutical industry. The team is committed to the company's values of sustainability and innovation, and their expertise has enabled the company to become a leader in the pharmaceutical industry.
For more information on RYBAR LABORATORIES LIMITED, their products, and services, please visit their website at www.rybarlabs.co.uk. The company's registered office address is 123 Main Street, London, UK.
